[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

KI and Bush



 From another list , thought you'd find this intriguing.

norm



-



---------------------------------------~->



There is 1 message in this issue.



Topics in this digest:



      1. Carlyle Group and Potassium Iodide

           From: Terry Lodge <tjlodge50@yahoo.com>





________________________________________________________________________

________________________________________________________________________



Message: 1

   Date: Fri, 26 Mar 2004 14:27:14 -0800 (PST)

   From: Terry Lodge <tjlodge50@yahoo.com>

Subject: Carlyle Group and Potassium Iodide



     Only 3 FDA-licensed firms can make and sell KI;

one of them is a SUBSIDIARY OF THE CARLYLE GROUP - so

the President of the U.S. and his family directly

benefit from the nuclear weapons and nuclear power

threats to public health and survival. . . .



http://www.sfgate.com/cgi-bin/article.cgi?file=/chronicle/archive/2004/03/21/BUG\

4E5O77A1.DTL



'A firm in position to profit'

by David Lazarus



The war in Iraq is a year old, and the

military-industrial complex is making out like a

bandit.



That at least was what protesters were telling me

the other day outside the Bechtel headquarters in

downtown San Francisco, where people were chanting,

the names of slain soldiers were read aloud and signs

said "Shut Down the War Profiteers."



"We're lining Bechtel's pockets at the expense of a

number of people's lives," said Paul LaFarge, a New

York artist who was in town for the demonstration.

But why Bechtel? The engineering giant, with about

$3 billion in Iraq- reconstruction contracts, has been

accused of no wrongdoing (unlike, say, Halliburton,

which the Pentagon says received millions of dollars

in kickbacks from Mideast subcontractors and

overcharged for services provided to U.S. troops).



"They're all part and parcel of the same thing,"

explained Amy Trachtenberg, a San Francisco artist, as

she paused from reciting the names of the dead just

feet from where somber-faced Bechtel workers were

slipping past a police barricade and into their office

building.



Yet Bechtel wasn't the only object of protesters'

ire. Michael Daloisio, a San Francisco teacher,

lamented that U.S. schools are struggling for cash

while a variety of companies are "making billions off

this illegal war."



Aside from Bechtel, he cited Halliburton,

Lockheed-Martin, ChevronTexaco and the Carlyle Group.

Well now.



Since the subject has come up, here's a little

something about Carlyle that most people don't know. I

can say that with confidence because even a Carlyle

representative said he didn't know until I pointed it

out to him.



The Washington investment firm, run by a who's who

of Republican heavyweights, including former Secretary

of State James Baker and former Defense Secretary

Frank Carlucci, has put money into about 300 different

companies and properties.



Those investments include United Defense Industries, a

maker of combat vehicles, naval guns and missile

launchers; and Sippican, a maker of submarine

systems and countermeasures to protect warships.

They also include a New Jersey pharmaceutical firm

called MedPointe, which just so happens to be one of

only three companies licensed by the U.S. Food and

Drug Administration to manufacture over-the-counter

potassium iodide pills.



That's significant because potassium iodide can

help protect against thyroid cancer in the event of

exposure to large amounts of radiation -- from a

small, easily transported nuclear weapon, say, or a

terrorist attack on a nuclear power plant. And that's

significant because, in June 2002, President Bush

signed into law the Public Health Security and

Bioterrorism Preparedness and Response Act. It

requires state and local officials to "provide

adequate protection" by distributing potassium iodide

to all public facilities within a few miles of a

nuclear power plant.



And that, in turn, is significant because if you're

one of just a handful of authorized makers of

potassium iodide, you're in a position to profit

handsomely if the worst-case scenario should actually

come to pass.



The Carlyle Group and another investment firm, the

Cypress Group, spent more than $400 million to acquire

a controlling stake in MedPointe in May 2001. Carlyle

alone owns about 42 percent of the firm.



Chris Ullman, a Carlyle spokesman, said he had no

idea that MedPointe produces a potassium iodide pill

called Thyro-Block. But when I explained what

Thyro-Block can be used for, he said this was

something to feel good about.



"Carlyle is proud to own companies that make

products that keep America safe," Ullman said, adding

that MedPointe allows Carlyle "to participate in the

specialty pharmaceutical space."



The other two FDA-approved makers of potassium

iodide are a small Florida outfit called Anbex that,

prior to the Sept. 11 attacks, sold its pill, Iosat,

primarily to doomsday-fearing survivalists; and a

Swedish outfit called Recip that brought its

lower-dosage pill, ThyroSafe, to the U.S. market in

2002.



John Hawkins, a MedPointe spokesman, said the

company has no current contracts to supply Thyro-Block

to any federal agency. He also said that sales of the

drug totaled less than $500,000 in 2003 (MedPointe

expects sales of all products, led by its allergy and

respiratory medicines, to reach $400 million this

year).



But Hawkins acknowledged that MedPointe has bid for

government contracts in the past. He also declined to

elaborate on the company's intentions for Thyro-Block.



"Our plans for all of our commercial products are

confidential," he said.



Asked whether production of Thyro-Block might be

increased due to continuing terrorism fears or whether

government officials have spoken with MedPointe about

ensuring an adequate national supply of potassium

iodide, Hawkins remained vague.



"For competitive reasons, our production plans for

the product and communications with customers are

confidential," he said.



This much at least is clear: If a "nuclear incident,"

as the bioterror law quaintly puts it, should occur,

MedPointe and the Carlyle Group would be uniquely

positioned to benefit from catastrophe.



That's not danger-mongering. That's a fact.

(For what it's worth, the New York Times reported

Friday that government officials have quietly revived

a cold-war program for rapidly analyzing fallout from

a nuclear attack on U.S. soil. The program is intended

to determine the perpetrator of an attack and help

coordinate a military response.)



Bechtel might make a convenient target for protesters

seeking a high- profile recipient of

Iraq-reconstruction dollars. "It's all about

capitalism," one masked protester, a self-styled

anarchist, told me outside the company's headquarters.



But to find a company truly poised to profit from

the unthinkable, he might want to make his way next

time to the Transamerica Pyramid. That's where

Carlyle's San Francisco office is located.





__________________________________

Do you Yahoo!?

Yahoo! Finance Tax Center - File online. File on time.

http://taxes.yahoo.com/filing.html





________________________________________________________________________

________________________________________________________________________







------------------------------------------------------------------------

Yahoo! Groups Links



<*> To visit your group on the web, go to:

     http://groups.yahoo.com/group/srs-action/



<*> To unsubscribe from this group, send an email to:

     srs-action-unsubscribe@yahoogroups.com



<*> Your use of Yahoo! Groups is subject to:

     http://docs.yahoo.com/info/terms/

 

------------------------------------------------------------------------











-- 

Coalition for Peace and Justice (http://www.coalitionforpeaceandjustice.org); and the UNPLUG Salem Campaign (http://www.unplugsalem.org); 321 Barr Ave., Linwood, NJ 08221; 609-601-8583/37; ncohen12@comcast.net. The Coalition for Peace and Justice is a chapter of Peace Action (http://www.peace-action.org). "You can say I'm a dreamer, but I'm not the only one" (Lennon). "Don't be late for your life" (Mary Chapin Carpenter).







************************************************************************

You are currently subscribed to the Radsafe mailing list. To

unsubscribe, send an e-mail to Majordomo@list.vanderbilt.edu  Put the

text "unsubscribe radsafe" (no quote marks) in the body of the e-mail,

with no subject line. You can view the Radsafe archives at

http://www.vanderbilt.edu/radsafe/